Welcome


The Ludwig Boltzmann Institute Applied Diagnostics (lbi:ad) is a translational research institution of the Ludwig Boltzmann Gesellschaft which is combining a team of transdisciplinary scientists, academic and industrial partners from several countries. It follows a new dual biomarker concept for tumor diagnosis. The focus of the institute lies on the development of non-invasive diagnostic methods combining molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis. The combination of these two methods will allow for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.


Frontiers in Urology
What is happening in Urology today?

Shahrokh F. Shariat, Head of the Department of Urology, initiated the meeting "Frontiers in Urology" in December 2017 and invited international pioneers and experts
1st Scientific Advisory Board Meeting


On February the 1st, 2018 our first Scientific Advisory Board Meeting took place. Five internationally renowned experts visited our institute with the purpose to evaluate and review
33rd International Austrian Winter Symposium - Radioactive Isotopes in Molecular Imaging


24th - 27th January 2018, the LBI:AD was part of the 33rd International Austrian Winter Symposium that was organized by the Austrian

Share This: